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ABSTRACT 
The risk of vascular events during pregnancy is substantially increased. Beyond comparatively frequent vascular diseases, preg-
nancy may lead also to the development of exceptionally rare vascular events such as the aortic dissection and aortic rupture 
which are conceivably endangering life conditions. Women with the connective tissue disorders and with a family history of 
the aorta diseases are especially prone to the aortic complications which may also develop in the absence of these risk factors 
due to the pregnancy-induced structural changes of the aortic wall. The preconception counselling is vital for patients with 
aortopathies to assess the risk of the aortic dissection and to establish the most appropriate care plan including the surgical 
intervention. This review presents the management guidelines in patients with the aortic dissection risk during pregnancy. 
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INTRODUCTION
The aortic dissection (AoD) during pregnancy is an ex-
tremely rare condition with the incidence of 14.5/1 000 000 in 
pregnant women vs 1.24/1 000 000 in non-pregnant ones [1]. 
The maternal mortality due to AoD is assessed for up to 
30% and the fetal mortality — up to 50% [2]. The reported 
mortality is estimated at 1% per hour during the first 48 h 
and exceeds 80% in the first month following the event [3]. 
RISK FACTORS FOR AORTIC DISSECTION 
The aortic dissection should be expected in patients 
with diagnosed connective tissue disorders: mainly Mar-
fan syndrome and the vascular type of Ehlers-Danlos syn-
drome, Loeys-Dietz, and Turner syndrome, and congenital 
malformations of the aorta like a bicuspid aortic valve. How-
ever, this catastrophic complication may appear in previ-
ously healthy pregnant patients [2]. In the report published 
by Yuan describing 122 pregnant patients with AoD, Mar-
fan syndrome (49.25%) and pregnancy itself (25.4%) were 
the leading reasons responsible for AoD. The Marfan pa-
tients developed AoD earlier during pregnancy: they were 
diagnosed with AoD during all trimesters, mainly in the 
last trimester, whereas AoD occurred in healthy pregnant 
women only in the 3rd trimester [4]. This data confirms the 
earliest observations that almost 50% of the cases of AoD 
arise in the last trimester or in the early post-partum period 
(33%) [5]. Kamel et al. have revealed that most of AoD events 
are observed between 6 months before and 3 months after 
delivery. The patients with the family history of aortic aneu-
rysms, AoD, congenital heart disease, past cardiac surgery, 
and trauma are at higher risk of AoD during pregnancy [2]. 
AoD or the rapid dilation of the aortic dimensions has been 
proven to increase the likelihood of aortic disruption in 
pregnant women as well. It has been assessed that women 
with the aortic root diameter below 40 mm have the risk 
of either the aortic dissection or other significant cardiac 
events to be 1 percent [6]. Table 1 presents the risk factors 
for AoD [7]. According to the Stanford classification, there 
are two types of AoD: type A which contributes to 79–89% 
of AoD cases in pregnant women and involves the ascend-
ing aorta with or without its descending part, and type B 
dissection (the descending part of the aorta only) which is 
associated with 11–21% of events [8]. 
PREGNANCY-INDUCED CHANGES WITHIN 
THE VASCULAR WALL 
Pregnancy is the cause of multiple changes within the 
circulatory system such as the increase in blood volume, 
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Table 1. The risk factors for the aortic dissection [7]
Increased aortic wall 
stress
Hypertension, preeclampsia, 
pheochromocytoma, stimulant agents 
(cocaine), trauma, torsional and 
deceleration injury, coarctation
Genetic conditions
Marfan syndrome, vascular Ehlers-Danlos, 
Turner, and Loeys-Dietz syndrome, 
bicuspid aortic valve, nonsyndromic 
familial thoracic aortic aneurysm and 
dissection, annuloaortic ectasia
Inflammatory vasculitis
Takayasu arteritis, Giant cell arteritis, 
Behcet arteritis
Others
Pregnancy, polycystic kidney 
disease, chronic corticosteroid, and 
immunosuppressive agents use
Infections
Syphilis, tuberculosis, pneumonia, 
pericarditis, osteomyelitis, sepsis 
cardiac output and left ventricular dimensions, heart rate, 
all of them require the aortic wall remodeling [9]. The aortic 
diameter and compliance increase throughout pregnancy, 
considerably during the third trimester and the post-par-
tum period. This effect is more enhanced in hypertensive 
and preeclamptic women [10]. The structural remodeling 
changes of the aortic wall observed within the tunica media 
and intima and induced by estrogen and progesterone as 
well as by circulating angiogenic factors, start early in preg-
nancy. They have been suggested as relevant to the aorta 
degeneration including the hyperplasia of aortic smooth 
muscle, the decrease in the amount of acid mucopolysac-
charides, and the disintegration of elastic fibers [10]. These 
hormonal-induced changes may result in the significant 
impairment of the vascular wall, thereby being a relevant 
reason for the AoD development during gestation [8]. 
PRECONCEPTION COUNSELLING 
The preconception counselling is vital for patients with 
aortopathies to assess the risk of AoD and to establish the 
most appropriate care plan. Young women with the family 
history of AoD or diagnosed connective tissue disorders 
and congenital aortic abnormality should be proposed the 
diagnostic evaluation prior conception. The preconception 
counselling is mandatory for patients with the enlarged 
aortic root in order to prevent AoD in pregnancy [11]. 
The assessment of the entire aorta with preferably mag-
netic resonance imaging (MRI) should be obligatory for pa-
tients considering pregnancy with the AoD risk factors in order 
to perform the elective root replacement if necessary [12, 13]. 
Although the aortic root of more than 4 cm in diameter 
and/or fast increase in the aorta size or AoD of ascending 
aorta in the past, mostly in the patients with connective tis-
sue disorders are the more frequent risk factors for AoD, the 
aortic dissection may develop in pregnant women without 
evident risk factors. Hence, AoD should be taken into con-
sideration while diagnosing chest pain in every pregnant 
woman [14]. 
In patients with the high risk of AoD or the aortic rupture 
during pregnancy, the need for the surgical intervention 
should be considered prior to the conception. The diam-
eter of the aorta when the scheduled surgical intervention 
should be offered depends on concomitant genetic diseases, 
a pace of the aorta diameter increase, and symptoms. Due 
to the extremely high risk of death exceeding 10%, preg-
nancy should be avoided by women with Marfan syndrome 
with the dilated aortic root ≥ 4 cm, when the rapid growth 
of the aorta dimension (> 0.5 cm per year) is observed in 
patients with bicuspid aortic valve and the dilation of the 
aorta ≥ 5 cm and by women with previous AoD type A. 
The surgical repair of the aorta should be performed even 
before considering conception in these cases [15, 16]. 
The safe diameter of the aorta in Marfan syndrome be-
low which the dissection will not develop in pregnancy has 
not been established, although AoD is uncommon when 
the aortic diameter is below 4 cm. In general, the patients 
with the prior aortic dissection should be discouraged from 
pregnancy. Women with the dilated aortic root ≥ 4.0–4.5 cm, 
with concomitant connective tissue diseases, the family 
history of AoD, or the indications for the surgical aortic 
valve replacement, should be offered the surgery before 
pregnancy planning [15]. Due to their teratogenicity, ACE 
inhibitors (angiotensyn converting enzyme inhibitors) and 
ARBs (angiotensin receptor blockers) should be discontin-
ued in favor of β-blockers prior conception. 
The genetic assessment should be ensured for the patients 
with the possible genetic diseases of the connective tissue [17]. 
PREGNANCY MANAGEMENT 
The patients with risk factors for AoD during pregnancy 
abovementioned require the constant and close surveil-
lance of the multidisciplinary medical team consisting of 
a specialist in perinatal and neonatal medicine, cardiolo-
gist, cardiothoracic surgeon and anesthesiologist in tertiary 
center of perinatal care [4]. The management options in 
gestation depend on the causes of the aortopathy, aortic 
dimension and concomitant diseases. The fundamental 
goal is the prevention of AoD and the aorta rupture which 
are life-threatening conditions with the maternal blood 
pressure and heart rate control in order to reduce their 
negative influence on the aortic wall. Beta-blockers, first 
of all, metoprolol and labetalol which possesses the ac-
tivity of both β- and α-adrenergic receptors blocker, are 
commonly safe and efficient agents during pregnancy and 
should be administered to alleviate aortic wall stress and to 
decrease the risk of the aorta enlargement. Atenolol should 
be avoided due to its association with the fetal growth re-
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striction [5]. The doses of β-blockers should be adjusted to 
gain the maximum effect, optimally the resting heart rate 
of < 60 bpm is desirable and needs to be maintained if well 
tolerated by the patient [18]. The rigorous blood pressure 
control, with the systolic blood pressure < 140 mmHg and 
the diastolic < 90 mmHg is advised. Patients with chronic 
hypertension and preeclampsia need special attention due 
to the increased risk of AoD during gestation [16]. Since the 
high risk for aortic complications decreases gradually after 
delivery, the therapy should be prolonged until the com-
pleted 3rd post-partum month [9]. If β-blockers are contrain-
dicated, calcium channel blockers may be administrated [7]. 
During pregnancy, the regular assessment of the aortic 
diameter with the echocardiographic measurement is man-
datory every 4 to 12 weeks till the 6th month post-partum. 
MRI without gadolinium contrast is recommended for the 
pregnant women with the aorta anomalies such as the dilata-
tion of the aortic arch, descending aorta, and/or abdominal 
aorta [19]. This diagnostic tool is favored to the computed 
tomography (CT) in order to avoid fetal exposure to the ion-
izing radiation. The initial MRI assessment of the entire aorta 
with subsequent regular echocardiographic monitoring in 
women with the aorta abnormalities who have never had 
pre-pregnancy examination is urged. However, CT due to its 
availability, particularly in an urgent situation, is often used and 
may be performed in pregnant patients in justified cases [7].
In addition to the routine fetal ultrasound examina-
tions, the fetal echocardiography should be offered for the 
prenatal diagnosis of congenital abnormalities related to 
the connective tissue disorders [15]. 
In the case of diagnosed or suspected genetic connec-
tive tissue disease in parents such as Marfan syndrome, 
Loeys-Dietz, and vascular Ehlers-Danlos syndrome, which 
are characterized by an autosomal dominant inheritance 
with the 50% risk of the transmission on offspring, the in-
vasive genetic prenatal testing should be offered (chorionic 
villus sampling or amniocentesis) [12]. 
The management of women of childbearing age with 
aorta diseases is presented in Table 2 [7]. 
The clinical symptoms of AoD are unspecific — it should 
be considered in patients reporting the acute chest pain 
(70%), back pain (21.7%) or epigastric and abdominal pain 
(2.5%) and/or with dyspnea, persistent cough, syncope and 
circulatory collapse [4]. The neurological injury or the peri-
cardial tamponade may also be present and usually manifest 
as syncope. The typical thoracic pain is rarely manifested in 
patients with dissection-related neurological events [20]. 
In order to confirm the diagnosis, the immediate MRI or 
CT should be carried out. The prompt surgical treatment 
for AoD is mandatory. The urgent surgery of AoD during 
pregnancy results in high maternal mortality and morbid-
ity. One month after the surgical intervention, the reported 
mortality rate is as high as 40–50%; the survivors suffer from 
significant complications such as renal and respiratory com-
promise, and severe neurologic impairment [21]. The pos-
sible surgical options in the case of AoD diagnosed during 
pregnancy depend on the gestation age. If necessary, the 
surgical repair of AoD with the continuation of pregnancy 
might be considered below the 28th week of gestation. 
Between the 28th and 32nd week, the decision of the aortic 
repair with the cesarean delivery depends on the mother 
and fetus condition. After the 32nd week of gestation, the 
cesarean delivery with the consecutive aorta repair in the 
same surgical session offers the best outcomes [22]. The 
main obstetric issue for these cases is the high risk of the 
peripartal hemorrhage mainly due to the use of large quan-
tities of anticoagulants required during the extracorporeal 
circulation. Haas et al. [23] recommend that the hysterec-
tomy just after the cesarean section should be considered 
as a prevention of the massive bleeding caused by antico-
agulants. The peripartal hysterectomy is the highest risk 
surgical procedure, including the risk of hemorrhage and 
should be considered only if additional indications like the 
uterine atony or placental pathology, exist. According to the 
data presented by Guo C. and al. [24], the Bentall procedure 
instead of repairing the arch with the deep hypothermia and 
the circulation arrest results in favorable outcomes. In the 
Table 2. The management of women of childbearing age with aorta 
diseases [7] 
Before pregnancy
Maternal risk assessment
 — echocardiography
 — cardiac MRI
Surgical procedure if necessary
Genetic testing
Management of concomitant diseases: 
diabetes, hypertension, obesity
Pregnancy
Management in a tertiary center of 
perinatal care by the team of specialists 
in perinatal medicine, cardiology and 
cardiothoracic surgery, anesthesiology, 
neonatology 
Echocardiography every 4–6 weeks
Hypotensive treatment — β-blockers
Genetic testing if indicated
Fetal echocardiography (18–20th week)
Regular fetal growth and wellbeing 
assessment
Treatment of comorbidities: diabetes, 
anemia, etc.
Delivery
Cesarean section
 — aortic diameter ≥ 4.0 cm: 
Marfan syndrome, AoD, severe aortic 
regurgitation, heart failure
 — aortic diameter ≥ 4.5 cm: other thoracic 
aortic aneurysms 
Vaginal delivery with the assisted second 
stage
 — aortic diameter < 4.0 cm
 — regional/epidural anesthesia
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large study on AoD in pregnancy, it has been reported that 
two types of procedures were performed the most often: 
the ascending aorta replacement (40%) and the Bentall 
operation (31.2%) with advantageous results [4]. 
The acute dissection of the descending aorta could be 
treated with vigorous hypotensive therapy unless severe, 
life-threatening complications occur [25]. 
DELIVERY 
The decision on the mode of delivery for the women 
with the aortopathy should be based on the thorough analy-
sis of the present maternal and fetal condition, medical 
history and should be made by the multidisciplinary team 
consisting of the obstetrician, cardiologist, anesthesiologist, 
and neonatologist. The recommendations on cesarean sec-
tion and vaginal delivery for the patients with aortopathies 
are presented in Table 2 [7]. 
POST-PARTUM
The AoD risk for patients with aortopathies remains high 
in post-partum thus they require close surveillance and care 
with β-blockers treatment for 3 months after delivery [10]. 
SUMMARY
The pregnant patients with the aortopathy, mainly Mar-
fan syndrome, should be assigned to the group of highest 
risk of AoD during pregnancy and the post-partum period. 
The preconception counselling is vital for the patients with 
aortopathies to assess the risk of AoD and to establish the 
most appropriate care plan: in patients with the high risk of 
AoD or the aortic rupture during pregnancy, the need for 
the surgical intervention should be considered prior to the 
conception. In the case of chest pain and dyspnea during 
pregnancy, the possibility of AoD should be strongly consid-
ered even regardless of other risk factors. For the pregnant 
patients with the known risk factors for AoD and for those 
presenting clinical symptoms of AoD, the close monitoring 
of pregnancy and the aorta condition should be offered in 
the tertiary perinatal care center where the cardiovascular 
procedures are immediately available. 
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